The neuroblastoma associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK translocated cancers

類似資料

• A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors
  著者:: Sasaki, Takaaki, 等
  出版事項: (2011)
• The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma
  著者:: Berry, Teeara, 等
  出版事項: (2012)
• Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
  著者:: Butrynski, James E., 等
  出版事項: (2010)
• ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT
  著者:: Debruyne, D N, 等
  出版事項: (2016)
• The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer
  著者:: Sasaki, Takaaki, 等
  出版事項: (2010)